Health and Healthcare

Celgene : CELG

All CELG Articles

433 Articles

Chris Lange | Apr 12, 2017 at 9:10 AM EDT

Short Sellers Back Off Major Biotechs

The March 31 short interest data have been compared with the previous report, and short interest decreased in most of…

Lee Jackson | Apr 8, 2017 at 9:35 AM EDT

Big Tech and Biotech Trades Highlight Insider Selling: Gap, Adobe, Celgene, Splunk and More

Insiders are using their last open windows to sell shares before they are closed for the earnings reports, and the…

Chris Lange | Mar 27, 2017 at 10:30 AM EDT

Short Interest Pulls Back in Major Biotechs

The health care sector in general has rallied since Trump took over the presidency, but now that his repeal of…

Lee Jackson | Mar 20, 2017 at 9:50 AM EDT

Jefferies Has 4 Red-Hot Biotech and Pharmaceutical Stocks to Buy Now

These are four top stocks to buy in a sector that has much more value than many on Wall Street.…

Chris Lange | Mar 10, 2017 at 10:30 AM EST

Major Biotechs See a Retreat in Short Interest

The February 28 short interest data have been compared with the previous report, and short interest decreased in most of…

Jon C. Ogg | Mar 9, 2017 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: American Express, Amgen, Encana, Gilead, Tesla and Many More

The top analyst upgrades, downgrades and initiations seen on Thursday include American Express, Amgen, Encana, Gilead Science and Tesla.

Lee Jackson | Mar 6, 2017 at 10:20 AM EST

Red-Hot Biotech Companies Highlight Jefferies Top Stocks to Buy

In this week's top stock picks from Jefferies, three very prominent biotechnology stocks are featured, including one that is a…

Chris Lange | Feb 28, 2017 at 10:15 AM EST

Short Sellers Hike Their Bets in Major Biotechs

The February 15 short interest data have been compared with the previous report, and short interest increased in all the…

Jon C. Ogg | Feb 24, 2017 at 1:45 PM EST

Is There More Than Meets the Eye on Celgene’s President, COO Retirement?

Celgene shares were trading lower on Friday due to a key management retirement. The problem is that this retirement is…

Lee Jackson | Feb 23, 2017 at 8:15 AM EST

Large Cap Biotech Stocks to Buy May Be the Cheapest in Years

One area is dirt cheap now, and in some cases pays dividends and has big growth prospects, and that is…

Chris Lange | Feb 10, 2017 at 9:55 AM EST

Major Biotechs Scare Off Loads of Short Sellers

As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears…

Lee Jackson | Jan 31, 2017 at 10:15 AM EST

4 Top Biotech Stocks With Big Upcoming Catalysts

In a new report, SunTrust Robinson Humphrey analysts are focused on upcoming catalysts for biotech stocks in their coverage universe.

Chris Lange | Jan 26, 2017 at 10:35 AM EST

Short Sellers Back Off Major Biotechs

As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears…

Chris Lange | Jan 25, 2017 at 11:25 AM EST

What to Expect From Major Health Care Stocks Reporting This Week

The health care sector has some of its biggest players reporting later this week, with one pharma giant’s report already…

Lee Jackson | Jan 23, 2017 at 9:55 AM EST

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

A new Jefferies research report makes the case that while market parameters are indeed expensive, there still are cheap stocks…

1 … 8 9 10 11 12 … 29

Celgene : CELG

All CELG Articles

Short Sellers Back Off Major Biotechs

Big Tech and Biotech Trades Highlight Insider Selling: Gap, Adobe, Celgene, Splunk and More

Short Interest Pulls Back in Major Biotechs

Jefferies Has 4 Red-Hot Biotech and Pharmaceutical Stocks to Buy Now

Major Biotechs See a Retreat in Short Interest

Top Analyst Upgrades and Downgrades: American Express, Amgen, Encana, Gilead, Tesla and Many More

Red-Hot Biotech Companies Highlight Jefferies Top Stocks to Buy

Short Sellers Hike Their Bets in Major Biotechs

Is There More Than Meets the Eye on Celgene’s President, COO Retirement?

Large Cap Biotech Stocks to Buy May Be the Cheapest in Years

Major Biotechs Scare Off Loads of Short Sellers

4 Top Biotech Stocks With Big Upcoming Catalysts

Short Sellers Back Off Major Biotechs

What to Expect From Major Health Care Stocks Reporting This Week

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Celgene : CELG

All CELG Articles

Short Sellers Back Off Major Biotechs

Big Tech and Biotech Trades Highlight Insider Selling: Gap, Adobe, Celgene, Splunk and More

Short Interest Pulls Back in Major Biotechs

Jefferies Has 4 Red-Hot Biotech and Pharmaceutical Stocks to Buy Now

Major Biotechs See a Retreat in Short Interest

Top Analyst Upgrades and Downgrades: American Express, Amgen, Encana, Gilead, Tesla and Many More

Red-Hot Biotech Companies Highlight Jefferies Top Stocks to Buy

Short Sellers Hike Their Bets in Major Biotechs

Is There More Than Meets the Eye on Celgene’s President, COO Retirement?

Large Cap Biotech Stocks to Buy May Be the Cheapest in Years

Major Biotechs Scare Off Loads of Short Sellers

4 Top Biotech Stocks With Big Upcoming Catalysts

Short Sellers Back Off Major Biotechs

What to Expect From Major Health Care Stocks Reporting This Week

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%